Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer

GÜNEY ESKİLER, GAMZEÖZMAN, ZEYNEP2020-11-112020-11-112020-06-09GÜNEY ESKİLER G., ÖZMAN Z., -Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer-, European Human Genetics Virtual Conference 2020, 6 - 09 Haziran 2020http://hdl.handle.net/20.500.12645/27371Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancerConference Paper6447249